You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
The Daily Progress System- A Recovery Support Tool to Reduce Health Disparities in Outpatient Substance Use Treatment
SBC: COG ANALYTICS, LLC Topic: 102ABSTRACTSubstance use disordersSUDsincluding opioid use disorderscontinue to be one of the most serious public health issues in the USleading to negative physical and mental health problemsfamily disruptionand premature deathAfrican Americans with drug use histories that are under criminal justice supervision are particularly vulnerable to experiencing the negative consequences associated with SUD ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Next generation HDAC inhibitors with superior potency, selectivity, and pharmacokinetic profiles for the treatment of liver ischemia-reperfusion injury
SBC: Lydex Pharmaceuticals LLC Topic: 300Hepatic ischemia reperfusion injuryIRIoccurs in many clinical situationssuch as traumahepatic surgerye gliver resection for tumor treatmentliver donation and transplantationshock and vascular diseasesHepatic I R causes severe liver injury and promotes inflammationleading to liver dysfunctionmultiple organ failure and deathIt also compromises long term outcomes after surgery and traumaCurrentlyno e ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Development of the GlycoFibrotyper for detection of liver fibrosis
SBC: GLYCOPATH INC Topic: 300Increasinglyalterations in N linked glycans have been reported for serum or plasmaor for the most abundant serum glycoproteinimmunoglobulin Gfrom large cohorts of samples representing rheumatoid arthritisdigestive diseasescancer and liver fibrosisIn the case of fibrosistwo tests have identified alterations in Nlinked glycosylation on both total IgG populations and on specific IgG moleculesBoth of ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Optimization of Betulinic Acid analogs for T-type calcium channel inhibition for non-addictive relief of chronic pain
SBC: Regulonix Topic: NIDAABSTRACT Chemotherapy induced peripheral neuropathyCIPNis a commonprevalenceand potentially doselimiting side effect of many cancer chemotherapy drug treatment regimensClinicallyCIPN presents with pain that is burningshooting or electric shock likeThe increase in prevalence of cancer coupled with an increase in the cancer survival rates due to chemotherapy regimens is transforming cancer pain into ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Accelerate Adoption of Galaxy Pro in the Biomedical Research Marketplace
SBC: GalaxyWorks LLC Topic: NHGRIProject Summary Galactic Core LLC aims to develop a robust, scalable, and managed service for performing enterprise-grade biomedical data analysis. The service will be based on the popular open-source Galaxy application (https://galaxyproject.org/), offering unlimited data storage and compute capabilities with an extremely powerful, flexible, and collaborative environment for analyzing data. ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Coherence Gated Doppler for Dentistry
SBC: CREATV MICROTECH INC Topic: NIDCRAbstractIf there were a simple and accurate means totake the pulseof a toothi efunctionally similar to a pulse oximeter that could be clipped on a tooth rather than the tip of a fingerthe quality and cost of dental care would be significantly improvedThe ability to measure dental pulp blood flow provides the most direct means to determine the viability of a tooth and is a vital piece of informatio ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Multielectrode Arrays for Neurotransmitter Detection with Fast Scan Cyclic Voltammetry
SBC: MICROPROBES FOR LIFE SCIENCE INC Topic: 101Project Summary Abstract The brain is by far the most complex and heterogeneous organ in the human bodyFor yearsthere has been a growing and unmet need to develop multielectrode arrays for neurotransmitter sensing in multiple brain regions simultaneouslyDisparate brain regions such as the nucleus accumbensstriatumprefrontal cortexhippocampusand others have been widely known to have greatly varying ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Identifying hereditary cancer patients in low-resource community cancer settings using an innovative informatics solution
SBC: SGgenomics, Inc. Topic: 101PROJECT SUMMARYHereditary cancer risk assessment in low resource community cancer settings is a signi cant unmet clinical needUnfortunatelymost community cancer clinics do not have adequate access to genetics expertise and patients are not systematically assessed for hereditary riskNew cost e ective and practical approaches are needed to assess and identify patients at risk for hereditary cancer c ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Discovery of Novel Peptidic Inhibitors of the Non-Catalytic Function of Focal Adhesion Kinase (FAK)
SBC: Faknostics, LLC Topic: 102PROJECT SUMMARY ABSTRACT Focal Adhesion KinaseFAKis a major cancer drug target that is overexpressed in multiple tumor typesFAK is a critical regulator of tumor survivalinvasionproliferationmetastasisand immune evasionCurrent FAK inhibitors that target the ATP binding pocket of the kinase domain do no effectively inhibit FAK in cancer because FAK also functions as a scaffolding proteinThe Focal Ad ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
The CRIT-ICU Biomarker Panel for Stratification of Mortality Risk in ARDS Patients
SBC: AQUALUNG THERAPEUTICS, CORP Topic: NHLBIPROJECT SUMMARYAcute Respiratory Distress SyndromeARDSis a devastatingly intense lung inflammatory disorder that annually afflicts more thanmillion individuals world widecases year in the U Swith an unacceptable mortality rate ofSubstantial clinical and biological heterogeneity within ARDS phenotypes has greatly impeded therapeutic developments to reduce mortalityAll therapies currently employed i ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health